Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.125    -0.025 (-2.17%)
Bid:
1.05
Ask:
1.20
Spread: 0.15 (14.286%)
Market Cap: £9.62m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Tern PLC: Equity Fundraise

8 May 2018 07:01

Tern PLC (TERN) Tern PLC: Equity Fundraise 08-May-2018 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


8 May 2018

 

Tern Plc ("Tern" or the "Company")

Equity Fundraise

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that it has raised £1,750,000 before expenses through an unconditional placing of 9,459,460 new ordinary shares of 0.02p each at a price of 18.50 pence per ordinary share (the "Placing") with a single institutional investor, utilising the existing share authorities granted at the 2018 AGM.

 

The net proceeds of the Placing will be used primarily to provide additional finance to develop the businesses of the existing portfolio companies and invest in new portfolio companies.

 

Al Sisto, CEO of Tern, commented on the Placing: "This Placing provides us with capital to continue delivering on our strategy to add to our portfolio of IoT businesses, and establish Tern as a leading IoT investment company. As promised at our AGM and our shareholder call on 26 April 2018, we will continue to provide regular updates on the progress being made by our portfolio companies which is the key value driver for Tern."

 

Application will be made for the 9,459,460 new ordinary shares to be admitted to AIM and it is expected that admission will take place and trading in the new ordinary shares will commence on 14 May 2018.

 

In accordance with the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules, the Company confirms that on completion of the Placing and following admission of the new ordinary shares to trading on AIM, the enlarged issued share capital will comprise 221,600,796 Ordinary Shares of 0.02p each. The Company does not hold any shares in Treasury. Therefore the total number of voting rights in the Company is 221,600,796.  The above figure may be used by shareholders in the Company as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

Enquiries

Tern Plc

Al Sisto/Sarah Payne

via Redleaf

 

WH Ireland

(NOMAD and joint broker)

Mike Coe/Ed Allsopp

 

Tel: 0117 945 3470

 

Whitman Howard

(Joint broker)

Nick Lovering/Francis North

 

Tel: 020 7659 1234

 

Redleaf Communications

Elisabeth Cowell/ Fiona Norman

 

Tel: 020 3757 6880

 

 

 


ISIN:GB00BFPMV798
Category Code:MSCH
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:5507
EQS News ID:682797
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
16th Dec 20247:01 amRNS-ROnline Investor Presentation and Q&A Session
16th Dec 20247:00 amRNSPlacing to raise £400,000
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSBoard Changes
25th Oct 20248:27 amRNSFurther re. Wyld Networks Rights Issue
15th Oct 20247:00 amRNSPlacing to raise £625,000
30th Sep 20245:04 pmRNSTotal Voting Rights
30th Sep 20247:00 amRNSDevice Authority Update
23rd Sep 202411:13 amRNSReplacement: Results of Open Offer
23rd Sep 202411:10 amRNSResult of General Meeting
23rd Sep 20247:00 amRNSResults of Open Offer
5th Sep 20247:00 amRNSOpen Offer and Notice of General Meeting
5th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
2nd Sep 202410:16 amRNSStatement re Wyld Networks Rights Issue
9th Aug 20247:00 amRNSPartial sale of Device Authority holding
27th Jun 202412:00 pmRNSResult of AGM
31st May 20245:00 pmRNSTotal Voting Rights
30th May 20247:00 amRNSResults for the year ended 31 December 2023
15th May 20247:00 amRNSExercise of Warrants
3rd May 20247:45 amRNSFurther re. Wyld Networks Warrant Exercise Process
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.